novel coronavirus pneumonia
Conditions
Interventions
experimental group:Sanhan Huashi Granules
control group:Lianhua Qingwen Granules
Sponsors
Affiliated Hospital of Changchun University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Patients meet the diagnosis standard of novel coronavirus infection in the ''Novel Coronavirus Pneumonia Treatment Protocol (Trial Version 9)''. 2. Clinical typing of mild, common type. 3. Having one or more of the symptoms of fever, cough, sore throat and malaise at the time of admission. 4. Admission to the hospital for no more than 24 hours. 5. Aged >=18 years. 6. Signed an informed consent form.
Exclusion criteria
Exclusion criteria: 1. Patients who had used similar proprietary Chinese medicine before enrollment; 2. Patients with immunodeficiency diseases or who have used immunosuppressants or glucocorticoids within the last 3 months; 3. Pregnant patients, pregnant patients and breastfeeding patients; 4. Allergic person (refers to person who is allergic to more than two kinds of drugs or food or is allergic to known ingredients of the drug used in this test); 5. Mental patients or those without self-awareness; 6. Patients who are considered unsuitable for clinical trials by the researcher.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Time of clinica disappearance rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Time of clinical recovery;Time of nucleic acid turning negative;Hospitalization days;The effect time to fever reduction;Conversion rate of severe illness;Disappearance rate of individual symptoms;Adverse events/reactions; | — |
Countries
China
Contacts
Public ContactTong Xiaolin
Outcome results
None listed